Awarding

The staff of the Scientific and Research Institute of First Aid named after N.V. Sklifosovsky, headed by Academician M.Sh. Khubutiya, was one of three entities in Russia that made the first lung transplantation, and today it can be surely stated that such kind of operations became a routine one.

The prize-winning work “Prevention and treatment of the primary lung graft dysfunction”.

“Charitable Foundation named after Maxim Klimov” was established on July 17, 2014. This Foundation was established in memory of a remarkable person, a talented businessman, a philosopher, who was dreaming of helping the talented scientists with any researches regarding medical fields.This Foundation was established for support and further development of transplantology and related medical trends.

Objectives of the Foundation

As is known, there is a large number of outstanding issues in the field of transplantology. These are: study of tolerance, improvement of immunosuppressive protocols, treatment of infections and many others. Scientists all over the world continue to work in this field. In July, 2014 there was established the Charitable Foundation “Charitable foundation named after Maxim Klimov” intended to contribute to the further development of transplantology.

Maxim Klimov is known in the world history of business as a brilliant strategist, a creator of one of the largest perfume and cosmetics store chain L'Etoile that became really the Empire of Beauty. The company established in 1997 now amounts about 900 stores being the undisputed world leader in the industry, permanently increasing its market share and its presence in the Russian Federation cities.

Maxim was a Person of global thinking; he introduced fearlessly new concepts, categories and trends in business taking ungraded, sometimes even revolutionary solutions. His activity could not be limited with only one project - he expanded the business frames, opened new companies. He was always interested in innovations, in new trends and developments. Untiring energy, bright acute mind, passionate desire to live and to create did not give the people around even a hint at the serious illness of this strong-will man. Maxim helped, supported, financed, and gave way to the lives of many people, trying to do it quietly, always remaining a mistery.

Medicine got to his sphere of interests, he became enthusiastic about the latest developments, and dreamt of creating a scientific research fund to support talented young scientists. He did not manage to complete this project; his life was discontinued at the most bright moment...

Maxim’s closest people decided to realize that idea. Suffusing with Maxim’s will his relatives and friends established a charity fund aimed at the support of further development of transplantology and related medical trends, such as immunology, study of stem cells and other aspects.His closest people decided to realize this idea. After his will, his relatives and friends established the Charitable Foundation which is aimed at the support of further development of transplantology and related medical fields, such as immunology, study of stem cells and other aspects.

It should be mentioned that people who lost Maxim – his mother, his wife, all closest people – have a marvelous courage. Despite all that deep emotional pain, they began to work, in fact maintaining that branch of medicine which should give a chance a lot of people with the disease that killed Maxim to live, to create, to love.

Digression to history

None of the achievements of modern medicine is as effective as human organ transplantation. Historically, a kidney was the first organ, transplantation of which has been performed as the experiment, and then in the clinic. Since then, the global transplantation community made a remarkable progress from single clinical attempts to widespread availability and recognition of transplantation as a treatment of acute and chronic diseases of heart, liver, kidneys and lungs. 50 years ago that was a risky experiment for

limited use, but now it has become a routine clinical practice in more than 80 countries around the world. What was available to a small number of patients of several leading medical centers in the richest countries is now changing the lives of patients with high- and middle-income in many countries.